Outcomes observed in Phase 2 trials under carefully controlled conditions may differ from those seen in real-world clinical practice
The odds of nausea, vomiting, and diarrhea by taspoglutide and lixisenatide are more than 80%, and over 50% by exenatide with the obvious dose-dependence ( The current view is that, consistent with GLP-1 RAs, the higher dose of TZP is associated with more GADE ( GADE of GLP-1 RAs occurs mainly in the first weeks of treatment and then subsides or stabilizes over time, but severe symptoms can also lead to discontinuation
Metalloproteinases are extracellular matrix remodeling enzymes, and any change in their regulatory mechanism may contribute to complications in T1DM 42
Another article looked at acetyl-l-cysteine and Clomid in women with unexplained infertility
Taken together, evidence from neuroscience, human research, and clinical practice suggests meaningful overlap between obesity and addiction-related mechanisms. Leggio says that his lab has long been interested in how gut-brain neuroendocrine pathways may influence alcohol use disorder (AUD)
What are lipo C injection site reactions